SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX)

Q: What does CUSIP 85205L107 represent in this 13F holders report?

CUSIP 85205L107 is the security identifier for SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share used to aggregate holder disclosures.

Q: How many institutions held SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in Q4 2019?

56 institutional investors reported SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share for Q4 2019. Use the holders table for investor-level position and value details.

CUSIP: 85205L107

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class: Equity / Common Stock, par value $.0001 per share
Shares outstanding: 75,607,738
Total 13F shares: 31,922,184
Share change: +570,587
Total reported value: $1,228,678,977
Price per share: $38.49
Number of holders: 56
Value change: +$28,086,854
Number of buys: 39
Number of sells: 23

Quarterly Holders Quick Answers

What is CUSIP 85205L107?
CUSIP 85205L107 identifies SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2020
Previous quarter: Q3 2019

Recent filing periods for CUSIP 85205L107:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of SWTX - SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	9.8%	7,406,307	$160,569,000	—	30 Sep 2019	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	9.6%	7,281,307	$157,859,000	—	30 Sep 2019	13F
PERCEPTIVE ADVISORS LLC	13F	Company	4.3%	3,217,522	$69,755,000	—	30 Sep 2019	13F
BVF INC/IL	13F	Company	3.8%	2,844,145	$61,661,000	—	30 Sep 2019	13F
Boxer Capital, LLC	13F	Company	2.7%	2,075,905	$45,006,000	—	30 Sep 2019	13F
CITADEL ADVISORS LLC	13F	Company	1.8%	1,323,817	$28,700,000	—	30 Sep 2019	13F
FMR LLC	13F	Company	1.5%	1,111,112	$24,089,000	—	30 Sep 2019	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	1.4%	1,050,888	$22,783,000	—	30 Sep 2019	13F
Samsara BioCapital, LLC	13F	Company	0.89%	676,602	$14,669,000	—	30 Sep 2019	13F
ArrowMark Colorado Holdings LLC	13F	Company	0.54%	409,892	$8,886,000	—	30 Sep 2019	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.53%	403,613	$8,750,000	—	30 Sep 2019	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.48%	363,260	$7,875,000	—	30 Sep 2019	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	0.48%	361,772	$7,843,000	—	30 Sep 2019	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.41%	310,000	$6,721,000	—	30 Sep 2019	13F
Artal Group S.A.	13F	Company	0.41%	308,526	$6,689,000	—	30 Sep 2019	13F
Laurion Capital Management LP	13F	Company	0.41%	307,980	$6,677,000	—	30 Sep 2019	13F
JENNISON ASSOCIATES LLC	13F	Company	0.33%	250,201	$5,424,000	—	30 Sep 2019	13F
CWM, LLC	13F	Company	0.07%	53,948	$4,446,000	—	30 Sep 2019	13F
FRANKLIN RESOURCES INC	13F	Company	0.26%	200,000	$4,336,000	—	30 Sep 2019	13F
NORGES BANK	13F	Company	0.26%	200,000	$4,336,000	—	30 Sep 2019	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.23%	175,000	$3,794,000	—	30 Sep 2019	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.22%	168,390	$3,651,000	—	30 Sep 2019	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.22%	165,862	$3,594,000	—	30 Sep 2019	13F
BlackRock Finance, Inc.	13F	Company	0.14%	103,579	$2,245,000	—	30 Sep 2019	13F
Monashee Investment Management LLC	13F	Company	0.11%	82,803	$1,795,000	—	30 Sep 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.09%	70,577	$1,530,000	—	30 Sep 2019	13F
VANGUARD GROUP INC	13F	Company	0.09%	70,000	$1,518,000	—	30 Sep 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.07%	50,760	$1,100,000	—	30 Sep 2019	13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC	13F	Company	0.05%	40,514	$878,000	—	30 Sep 2019	13F
Marshall Wace North America L.P.	13F	Company	0.05%	35,761	$775,000	—	30 Sep 2019	13F
CREDIT SUISSE AG/	13F	Company	0.04%	27,319	$592,000	—	30 Sep 2019	13F
DC Investments Management, LLC	13F	Company	0.04%	26,513	$575,000	—	30 Sep 2019	13F
NORTHERN TRUST CORP	13F	Company	0.02%	18,124	$393,000	—	30 Sep 2019	13F
Weiss Asset Management LP	13F	Company	0.02%	17,194	$373,000	—	30 Sep 2019	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.02%	14,392	$312,000	—	30 Sep 2019	13F
JANE STREET GROUP, LLC	13F	Company	0.02%	14,142	$307,000	—	30 Sep 2019	13F
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP	13F	Company	0.02%	12,500	$271,000	—	30 Sep 2019	13F
TUDOR INVESTMENT CORP ET AL	13F	Company	0.01%	10,276	$223,000	—	30 Sep 2019	13F
MORGAN STANLEY	13F	Company	0.01%	6,432	$139,000	—	30 Sep 2019	13F
UBS Group AG	13F	Company	0%	2,344	$51,000	—	30 Sep 2019	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,014	$22,000	—	30 Sep 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	400	$9,000	—	30 Sep 2019	13F
Catalyst Capital Advisors LLC	13F	Company	0%	260	$6,000	—	30 Sep 2019	13F
Legal & General Group Plc	13F	Company	0%	195	$4,000	—	30 Sep 2019	13F

Institutional Holders of SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) as of Q4 2019

As of 31 Dec 2019, SPRINGWORKS THERAPEUTICS, INC. - Common Stock, par value $.0001 per share (SWTX) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 31,922,184 shares. The largest 10 holders included ORBIMED ADVISORS LLC, Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, BVF INC/IL, BOXER CAPITAL, LLC, FMR LLC, CITADEL ADVISORS LLC, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Samsara BioCapital, LLC, and BlackRock Inc.. This page lists 56 institutional shareholders reporting positions in this security for the Q4 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2019 vs Q3 2019 Across Filers

Q3 2019 holders

Q4 2019 holders

Holder diff

Investor	Q3 2019 Shares	Q4 2019 Shares	Share Diff	Share Chg %	Q3 2019 Value $	Q4 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.